AR007240A1 - Analogos de vitamina d3 fluorados, mezclas y composiciones farmaceuticas que los contienen y su empleo para elaborar una composicion farmaceutica - Google Patents
Analogos de vitamina d3 fluorados, mezclas y composiciones farmaceuticas que los contienen y su empleo para elaborar una composicion farmaceuticaInfo
- Publication number
- AR007240A1 AR007240A1 ARP970102157A ARP970102157A AR007240A1 AR 007240 A1 AR007240 A1 AR 007240A1 AR P970102157 A ARP970102157 A AR P970102157A AR P970102157 A ARP970102157 A AR P970102157A AR 007240 A1 AR007240 A1 AR 007240A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- vitamin
- fluorated
- analogs
- develop
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Análogos de vitamina D3 fluorados de fórmula (I), en donde R es hidrógeno, fluor o hidroxilo, y X es =CH2 o cuando R es hidroxilo, X es hidrógeno o=CH2, el cual es de utilidad en el tratamiento de trastornos hiperproliferativos,e nfermedades neoplásicas y enfermedades de lasglándulas sebáceas. Asimismo, se describe una mezcla y una composición farmacéutica que los contiene y su empleo para la elaboración de unacomposición farmacéutica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1818796P | 1996-05-23 | 1996-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007240A1 true AR007240A1 (es) | 1999-10-27 |
Family
ID=21786696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102157A AR007240A1 (es) | 1996-05-23 | 1997-05-21 | Analogos de vitamina d3 fluorados, mezclas y composiciones farmaceuticas que los contienen y su empleo para elaborar una composicion farmaceutica |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5888994A (es) |
| EP (1) | EP0808831B1 (es) |
| JP (1) | JP2858571B2 (es) |
| KR (1) | KR100237523B1 (es) |
| CN (1) | CN1081184C (es) |
| AR (1) | AR007240A1 (es) |
| AT (1) | ATE195514T1 (es) |
| AU (1) | AU720098B2 (es) |
| BR (1) | BR9703373A (es) |
| CA (1) | CA2204478C (es) |
| CO (1) | CO4840512A1 (es) |
| CZ (1) | CZ157997A3 (es) |
| DE (1) | DE69702812T2 (es) |
| DK (1) | DK0808831T3 (es) |
| ES (1) | ES2150719T3 (es) |
| GR (1) | GR3034832T3 (es) |
| HR (1) | HRP970274A2 (es) |
| HU (1) | HUP9700927A3 (es) |
| IL (1) | IL120842A0 (es) |
| MA (1) | MA24345A1 (es) |
| NO (1) | NO971934L (es) |
| NZ (1) | NZ314838A (es) |
| PL (1) | PL320131A1 (es) |
| PT (1) | PT808831E (es) |
| SG (1) | SG50831A1 (es) |
| TR (1) | TR199700418A2 (es) |
| TW (1) | TW374762B (es) |
| UY (1) | UY24563A1 (es) |
| YU (1) | YU19997A (es) |
| ZA (1) | ZA974334B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO971934L (no) * | 1996-05-23 | 1997-11-24 | Hoffmann La Roche | Flourinerte vitamin D3 -analoger |
| EP0981523B1 (en) * | 1997-05-16 | 2005-12-07 | Woman & Infants Hospital | Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof |
| US6017908A (en) * | 1997-05-16 | 2000-01-25 | Women And Infants Hospital | 3-EPI vitamin D2 compounds and uses thereof |
| JP4219553B2 (ja) * | 1997-09-08 | 2009-02-04 | エフ．ホフマン−ラ ロシュ アーゲー | １，３−ジヒドロキシ−２０，２０−ジアルキル−ビタミンｄ３類似体 |
| AU3390400A (en) * | 1999-03-05 | 2000-09-21 | Johns Hopkins University, The | Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound |
| US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
| EP1812011A1 (en) | 2004-11-12 | 2007-08-01 | Bioxell S.p.a. | Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| EP1993559B1 (en) | 2006-02-03 | 2016-06-22 | OPKO Renal, LLC | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| ES2670029T3 (es) | 2006-06-21 | 2018-05-29 | Opko Ireland Global Holdings, Ltd. | Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D |
| HRP20231142T3 (hr) | 2007-04-25 | 2024-01-05 | Eirgen Pharma Ltd. | Kontrolirano oslobađanje 25-hidroksivitamina d |
| CA2683628C (en) | 2007-04-25 | 2018-03-06 | Cytochroma Inc. | Method of treating vitamin d insufficiency and deficiency |
| WO2011123476A1 (en) | 2010-03-29 | 2011-10-06 | Cytochroma Inc. | Methods and compositions for reducing parathyroid levels |
| WO2012065050A1 (en) | 2010-11-12 | 2012-05-18 | Wisconsin Alumni Research Foundation | 22-haloacetoxy-homopregnacalciferol analogs and their uses |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| CN108883120A (zh) | 2016-03-28 | 2018-11-23 | 欧普科爱尔兰环球控股有限公司 | 维生素d治疗方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5039671A (en) * | 1984-12-19 | 1991-08-13 | Hoffmann-La Roche Inc. | Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds |
| US5145846A (en) * | 1988-01-20 | 1992-09-08 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
| GB9007236D0 (en) * | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| US5206230A (en) * | 1991-06-05 | 1993-04-27 | Daikin Industries, Ltd. | Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same |
| US5210237A (en) * | 1991-08-27 | 1993-05-11 | Daikin Industries, Ltd. | Vitamin d3 analogues |
| US5200536A (en) * | 1992-02-10 | 1993-04-06 | Daikin Industries Ltd. | Fluorine-containing vitamin D3 analogues |
| GB9206648D0 (en) * | 1992-03-26 | 1992-05-06 | Leo Pharm Prod Ltd | Chemical compounds |
| DE69304279T2 (de) * | 1992-05-20 | 1997-02-20 | Hoffmann La Roche | Fluorierte Analoge Vitamins D3 |
| CA2096105A1 (en) * | 1992-10-07 | 1994-04-08 | Enrico Giuseppe Baggiolini (Deceased) | Vitamin d3 fluorinated analogs |
| TW267161B (es) * | 1992-11-20 | 1996-01-01 | Hoffmann La Roche | |
| US5428029A (en) * | 1993-11-24 | 1995-06-27 | Hoffmann-La Roche Inc. | Vitamin D3 fluorinated analogs |
| US5384314B1 (en) * | 1994-03-11 | 1997-08-05 | Hoffmann La Roche | 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol |
| NO971934L (no) * | 1996-05-23 | 1997-11-24 | Hoffmann La Roche | Flourinerte vitamin D3 -analoger |
-
1997
- 1997-04-25 NO NO971934A patent/NO971934L/no unknown
- 1997-04-28 TW TW086105570A patent/TW374762B/zh active
- 1997-05-05 CA CA002204478A patent/CA2204478C/en not_active Expired - Fee Related
- 1997-05-12 SG SG1997001491A patent/SG50831A1/en unknown
- 1997-05-14 DK DK97107848T patent/DK0808831T3/da active
- 1997-05-14 PT PT97107848T patent/PT808831E/pt unknown
- 1997-05-14 AT AT97107848T patent/ATE195514T1/de not_active IP Right Cessation
- 1997-05-14 EP EP97107848A patent/EP0808831B1/en not_active Expired - Lifetime
- 1997-05-14 ES ES97107848T patent/ES2150719T3/es not_active Expired - Lifetime
- 1997-05-14 DE DE69702812T patent/DE69702812T2/de not_active Expired - Fee Related
- 1997-05-16 US US08/857,883 patent/US5888994A/en not_active Expired - Fee Related
- 1997-05-16 NZ NZ314838A patent/NZ314838A/en unknown
- 1997-05-16 IL IL12084297A patent/IL120842A0/xx unknown
- 1997-05-19 ZA ZA9704334A patent/ZA974334B/xx unknown
- 1997-05-20 YU YU19997A patent/YU19997A/sh unknown
- 1997-05-20 HR HR60/018,187A patent/HRP970274A2/xx not_active Application Discontinuation
- 1997-05-20 JP JP9129238A patent/JP2858571B2/ja not_active Expired - Fee Related
- 1997-05-21 AR ARP970102157A patent/AR007240A1/es active IP Right Grant
- 1997-05-21 CO CO97027698A patent/CO4840512A1/es unknown
- 1997-05-21 HU HU9700927A patent/HUP9700927A3/hu unknown
- 1997-05-21 MA MA24629A patent/MA24345A1/fr unknown
- 1997-05-22 KR KR1019970019921A patent/KR100237523B1/ko not_active Expired - Fee Related
- 1997-05-22 CZ CZ971579A patent/CZ157997A3/cs unknown
- 1997-05-22 UY UY24563A patent/UY24563A1/es not_active Application Discontinuation
- 1997-05-22 PL PL97320131A patent/PL320131A1/xx unknown
- 1997-05-22 AU AU23572/97A patent/AU720098B2/en not_active Ceased
- 1997-05-23 CN CN97111050A patent/CN1081184C/zh not_active Expired - Fee Related
- 1997-05-23 TR TR97/00418A patent/TR199700418A2/xx unknown
- 1997-05-23 BR BR9703373A patent/BR9703373A/pt not_active Application Discontinuation
-
2000
- 2000-11-13 GR GR20000402519T patent/GR3034832T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR007240A1 (es) | Analogos de vitamina d3 fluorados, mezclas y composiciones farmaceuticas que los contienen y su empleo para elaborar una composicion farmaceutica | |
| ES2052881T3 (es) | Agentes reductores de la presion sanguinea. | |
| ES2137991T3 (es) | Eniantinas y derivados de eniantina para la lucha contra los endoparasitos. | |
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| ES2181866T3 (es) | Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2119325T3 (es) | Compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| MX9301296A (es) | Nuevos compuestos de diarilsulfonamidas, procedimiento para su preparacion y formulado farmaceutico que los comprende. | |
| ES2054716T3 (es) | Bis-naftalimidas, su obtencion y empleo. | |
| BR9810729B1 (pt) | composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante. | |
| ES2054860T3 (es) | Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos. | |
| HN1999000080A (es) | Derivados de isotiazol utiles como agentes anticancerosos. | |
| BR0317891A (pt) | Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas | |
| DK165440C (da) | Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele | |
| CO4950531A1 (es) | Analogos de la vitamina d3 composciiones farmaceuticas que los contienen | |
| ES2130312T3 (es) | Nuevos derivados de tetrazina con actividad acaricida. | |
| PA8532001A1 (es) | Bifenilcarboxamidas utiles como agentes reductores de lipidos | |
| ES2143734T3 (es) | Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| BR0015939A (pt) | Sistemas terapêuticos transdérmicos com estabilidade aperfeiçoada e um processo para a sua preparação | |
| ES2119326T3 (es) | Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| PA8542601A1 (es) | Bifenilcarboxamidas reductoras de lipidos | |
| ES2120145T3 (es) | Compuestos bi-aromaticos acetilenados con grupo adamantilo, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| ES2165029T3 (es) | Hidrofluoruros de amina y su utilizacion como agentes para la higiene bucal. | |
| AR012546A1 (es) | Utilizacion de al menos un compuesto seleccionado entre el grupo que comprende los sogaoles y los gingeroles para la preparacion de una composiciondesodorante, sogaol, extracto bruto y extracto purificado que contiene el sogaol y la composicion desodorante obtenida. | |
| ES2116612T3 (es) | Nuevas bis-naftalimidas para el tratamiento del cancer. | |
| AR012598A1 (es) | Un analogo de vitamina d3 con dos cadenas laterales sobre el c-20, utilizaciones del mismo, un metodo para obtenerlo , un medicamento que contiene a dicho analogo y un compuesto util como intermedio para obtener dicho analogo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |